Ronca, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 1.355
AS - Asia 1.159
EU - Europa 236
SA - Sud America 162
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 29
Totale 2.998
Nazione #
US - Stati Uniti d'America 1.289
SG - Singapore 638
CN - Cina 288
BR - Brasile 125
VN - Vietnam 94
IT - Italia 83
HK - Hong Kong 43
CA - Canada 35
GB - Regno Unito 24
FR - Francia 20
DE - Germania 18
AR - Argentina 13
IN - India 12
MX - Messico 12
BD - Bangladesh 11
EC - Ecuador 11
FI - Finlandia 11
CZ - Repubblica Ceca 10
PL - Polonia 10
JP - Giappone 9
SA - Arabia Saudita 9
IE - Irlanda 8
NL - Olanda 8
IQ - Iraq 7
SE - Svezia 7
UA - Ucraina 7
ZA - Sudafrica 7
ID - Indonesia 6
CO - Colombia 5
EG - Egitto 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
ES - Italia 4
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
NG - Nigeria 4
NP - Nepal 4
CR - Costa Rica 3
GR - Grecia 3
JM - Giamaica 3
PH - Filippine 3
PK - Pakistan 3
RU - Federazione Russa 3
AL - Albania 2
BO - Bolivia 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
KE - Kenya 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
ET - Etiopia 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.942
Città #
Singapore 295
San Jose 188
Ashburn 173
Shanghai 107
The Dalles 87
Beijing 76
Santa Clara 61
Council Bluffs 57
Hong Kong 39
Los Angeles 37
Ho Chi Minh City 34
Dallas 33
New York 26
Boardman 22
Milan 20
Hanoi 19
North Bergen 14
Rome 14
Phoenix 13
Buffalo 12
Montreal 12
Helsinki 11
Princeton 11
São Paulo 11
Brooklyn 10
Seattle 9
Warsaw 9
Brno 8
Dublin 8
Atlanta 7
Chicago 7
Truccazzano 7
Amsterdam 6
Da Nang 6
Johannesburg 6
Queens 6
Riyadh 6
Tokyo 6
Charlotte 5
Figino 5
Frankfurt am Main 5
Quito 5
San Francisco 5
Stockholm 5
Assago 4
Baghdad 4
Benin City 4
Boston 4
Campinas 4
Mexico City 4
Munich 4
Ottawa 4
Biên Hòa 3
Cairo 3
Chino 3
Cleveland 3
Denver 3
Dhaka 3
Dorridge 3
Giugliano in Campania 3
Haiphong 3
Hangzhou 3
Hialeah 3
Hillsboro 3
Houston 3
Hải Dương 3
Lawrence 3
London 3
Naples 3
Orem 3
Oskaloosa 3
Philadelphia 3
Porto Alegre 3
Pune 3
Rio de Janeiro 3
Rochester 3
San José 3
Secaucus 3
São Bernardo do Campo 3
The Bronx 3
Washington 3
Watsonville 3
Wilmington 3
Abbeville 2
Ambato 2
Ankara 2
Athens 2
Birmingham 2
Bishkek 2
Bossier City 2
Brasília 2
Brownsville 2
Bucharest 2
Budrio 2
Buenos Aires 2
Campos dos Goytacazes 2
Can Tho 2
Caserta 2
Changsha 2
Chennai 2
Totale 1.662
Nome #
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement 125
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 108
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 97
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 97
Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis 89
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation 85
Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer 79
Gut-Liver Immune Traffic: Deciphering Immune-Pathogenesis to Underpin Translational Therapy 76
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 74
Is ChatGPT a reliable tool in Autoimmune Hepatitis? 72
Ex situ Normothermic Split Liver Machine Perfusion: Protocol for Robust Comparative Controls in Liver Function Assessment Suitable for Evaluation of Novel Therapeutic Interventions in the Pre-clinical Setting 67
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency 66
Conversion of CD4+T cells to functioning and epigenetically stable induced regulatory T cells in patients with primary biliary cholangitis 64
The Immunological Basis of Liver Allograft Rejection 62
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 61
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 59
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis 58
Breakdown in hepatic tolerance and its relation to autoimmune liver diseases 58
Predictors of serious adverse events and non‐response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 58
Prognostic models in primary biliary cholangitis 57
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 56
Epidemiology and predictors of splanchnic thrombosis in liver transplant candidates: a single centre study 56
New Therapeutic Targets in Autoimmune Cholangiopathies 55
Toward precision medicine in primary biliary cholangitis 55
Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 55
Expression of E-cadherin by CD8+ T cells promotes their invasion into biliary epithelial cells 55
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 55
The Human Immune Response to Cadaveric and Living Donor Liver Allografts 54
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 54
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 54
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 53
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 53
Assessment of advanced age candidates for liver transplantation warrants more caution 53
Organ Restoration With Normothermic Machine Perfusion and Immune Reaction 52
Type 2 Autoimmune Hepatitis and Nonadherence to Medication Correlate With Premature Birth and Risk of Postpartum Flare 52
Donation after Circulatory Death Liver Transplantation in Paediatric Recipients 50
Precision medicine in primary biliary cholangitis 47
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 46
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 46
Quality of life in patients with primary biliary cholangitis: A cross-geographical comparison 46
Use of immunosuppression in non-transplant hepatology 45
Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 44
An “unmodifiable” risk factor that has been modified 44
The invasion of the biliary epithelial cells by CD103+ CD69+ in-traepithelial cells CD8+ T lymphocyte and its role in the patho-genesis of primary biliary cholangitis 42
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 41
Reply to: "A spotlight on natural killer cells in primary biliary cholangitis" 39
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 38
Moving Forward to New Trends in Liver Transplantation 37
The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects 35
From unmet needs to new possibilities: PPAR-targeted therapies in the journey of people living with Primary Biliary Cholangitis 25
Navigating Neoplasm Risk in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis 25
Seronegative Autoimmune Hepatitis in Adults Is a Rare Entity Often Obscured by Suboptimal Diagnostic Assessment 24
Totale 2.998
Categoria #
all - tutte 17.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 0 0 0 0 0 5 0 8 0
2022/202322 7 1 4 0 2 0 0 0 2 4 2 0
2023/2024241 3 2 6 2 1 4 82 13 11 6 43 68
2024/2025594 17 5 8 11 6 92 36 62 84 138 74 61
2025/20261.513 224 73 52 113 88 78 406 91 79 89 101 119
2026/2027615 106 131 290 88 0 0 0 0 0 0 0 0
Totale 2.998